Mozambique vs Venezuela, Bolivarian Republic of: Treatment success rate for patients treated for MDR-TB
Mozambique
77.0%
in 2022
Venezuela, Bolivarian Republic of
78.0%
in 2022
Mozambique rank
61st
Venezuela, Bolivarian Republic of rank
59th
Treatment success rate for patients treated for MDR-TB over time
- Mozambique
- Venezuela, Bolivarian Republic of
How they compare
Venezuela, Bolivarian Republic of currently reports 78.0% against 77.0% in Mozambique, a difference of 1.0%.
The two have swapped places 2 times across 17 shared years of data; in 2006 it was Venezuela, Bolivarian Republic of ahead.
Mozambique ranks 61st and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
Across the 3 decades both report, Mozambique averaged higher in 1 and Venezuela, Bolivarian Republic of in 2.
Head to head by decade
| Decade | Mozambique | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 64.2% | 35.8% | Venezuela, Bolivarian Republic of |
| 2010s | 48.7% | 62.4% | 13.7% | Venezuela, Bolivarian Republic of |
| 2020s | 76.3% | 70.0% | 6.3% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Mozambique or Venezuela, Bolivarian Republic of?
- Venezuela, Bolivarian Republic of, at 78.0% against 77.0% in Mozambique as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Mozambique and Venezuela, Bolivarian Republic of?
- 1.0%, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Mozambique and Venezuela, Bolivarian Republic of?
- 17 years are reported by both, from 2006 to 2022.
- How do Mozambique and Venezuela, Bolivarian Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Mozambique ranks 61st and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.